14 results
10-K
2023 FY
NMRA
Neumora Therapeutics Inc.
7 Mar 24
Annual report
4:05pm
indication as the original innovative drug or for another indication, where the applicant does not own or have a legal right of reference to all … a Center for Medicare and Medicaid Innovation at the CMS to test innovative payment and service delivery models to lower Medicare and Medicaid spending
8-K
EX-99.1
NMRA
Neumora Therapeutics Inc.
8 Jan 24
Regulation FD Disclosure
8:32am
Data on File.. PTE = patent term extension. 16
2024 and 2025 Are Catalyst Rich Years for Neumora Built at Scale Leading Pipeline Innovative Approach
424B4
NMRA
Neumora Therapeutics Inc.
18 Sep 23
Prospectus supplement with pricing info
4:12pm
treatment for MDD. Dr. Nick Brandon, our Chief Scientific Officer, previously served as Chief Scientist of AstraZeneca’s Neuroscience Innovative Medicines … success is highly dependent on our ability to discover, develop and obtain marketing approval for new and innovative products on a cost-effective basis
S-1/A
NMRA
Neumora Therapeutics Inc.
11 Sep 23
IPO registration (amended)
6:07am
served as Chief Scientist of AstraZeneca’s Neuroscience Innovative Medicines and Early Development Division, as well as Head of Psychiatry and Behavioral … technological change. Our success is highly dependent on our ability to discover, develop and obtain marketing approval for new and innovative products
S-1
qw2qtv3013xu
25 Aug 23
IPO registration
5:03pm
DRS/A
yy3q euy85
9 Aug 23
Draft registration statement (amended)
12:00am
DRS/A
unrar
30 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
r8ocg5gt 958z
2 May 23
Draft registration statement (amended)
12:00am
DRS/A
zucqnkg
2 Sep 22
Draft registration statement (amended)
12:00am
DRS/A
to8u wn6fn
10 Jun 22
Draft registration statement (amended)
12:00am
DRS/A
86z4hnuahytquvni
2 May 22
Draft registration statement (amended)
12:00am
DRS/A
xawi xq4jm12
23 Dec 21
Draft registration statement (amended)
12:00am
DRS
tmkq3u
8 Nov 21
Draft registration statement
12:00am
- Prev
- 1
- Next